ASSURA PLC - Notifications of transactions by Persons Discharging Managerial Responsibilities (PDMRs)

Notifications of transactions by Persons Discharging Managerial Responsibilities (“PDMRs”)

Assura plc
(Incorporated in England and Wales)
(Company Number: 09349441)
LEI number: 21380026T19N2Y52XF72
LSE Share Code: AGR
JSE Share Code: AHR
ISIN Code: GB00BVGBWW93
("Assura" or the "Company")

Notifications of transactions by Persons Discharging Managerial Responsibilities
("PDMRs")

Assura plc (the "Company"), the UK's leading diversified healthcare REIT, announces the
following transaction in respect of Ordinary Shares of 10 pence each in the Company
("Ordinary Shares"):

   •   Steven Noble, CIO, has acquired 257,870 Ordinary Shares at 38.59p

Following the transactions, the total beneficial interest of Steven Noble and his connected
persons in the Ordinary Shares is 501,311.

The Notification of Dealing Forms can be found below.

This notification is made in accordance with the Market Abuse Regulation.

                                Notification of dealing form

       1    Details of the person discharging managerial responsibilities/person
            closely associated

       a)   Name              Steven Noble

       2    Reason for the notification

       a)   Position/status   Chief Investment Officer

       b)   Initial           Initial notification
            notification/
            Amendment

       3    Details of the issuer, emission allowance market participant, auction
            platform, auctioneer or auction monitor

       a)   Name              Assura plc

       b)   LEI               21380026T19N2Y52XF72

       4    Details of the transaction(s): section to be repeated for (i) each type
            of instrument; (ii) each type of transaction; (iii) each date; and (iv)
            each place where transactions have been conducted

      a)    Description of    Ordinary shares of 10 pence each
            the financial
            instrument,
            type of
            instrument

            Identification    GB00BVGBWW93
            code
      b)    Nature of the
            transaction       Acquisition of Ordinary Shares



      c)    Price(s) and
            volume(s)          Price(s)          Volume(s)

                               £0.3859 GBP       257,870



      d)    Aggregated
            information

            -   Aggregated     Aggregate Price   Aggregate       Aggregate Total
                volume                           Volume

            -   Price          £0.3859 GBP       257,870         £99,512.03 GBP


      e)    Date of the       14 November 2024
            transaction

      f)    Place of the      XLON
            transaction



For more information, please contact:

Assura plc                                    Tel: 0161 515 2043
David Purcell, Investor Relations Director    Email: Investor@assura.co.uk

FGS Global                                    Tel: 0207 251 3801
Gordon Simpson                                Email: Assura@fgsglobal.com

Notes to Editors
Assura plc is the UK's leading diversified healthcare REIT. Assura enables better health
outcomes through its portfolio of more than 600 healthcare buildings, from which over six
million patients are served.

A UK REIT based in Altrincham, Assura is a constituent of the FTSE 250 and the EPRA*
indices. As at 30 September 2024, Assura's portfolio was valued at £3.2 billion and has a
strong track record of growing financial returns and dividends for shareholders.
At Assura, we BUILD for health, having developed over 100 new healthcare buildings in our
history, and at the heart of our strategy sits The Bigger Picture; Healthy Environment (E),
Healthy Communities (S), Healthy Business (G).

Further information is available at www.assuraplc.com

*EPRA is a registered trademark of the European Public Real Estate Association
Assura plc LEI code: 21380026T19N2Y52XF72



14 November 2024



Corporate Advisor and JSE Sponsor

Nedbank Corporate and Investment Banking, a division of Nedbank Limited

Date: 14-11-2024 03:00:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.